From Earlier: GARP Research Initiates RPX Coverage: Buy
GARP Research initiated RPX (NASDAQ: RPXC) coverage today with a Buy rating on the company.
In the report, GARP Research stated, "We are initiating coverage of RPX with a Buy rating. We think the company's novel subscription-based approach to mitigating patent risk should drive double-digit revenue growth over the next several years."
Shares of RPX were trading at $14.65 at the time of posting, down 0.88% from Tuesday's market close.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.